Only show
results from:

Sort results by:

Display preferences
83 results sorted by relevancy Results per page:
Keryx Biopharmaceuticals Settles License Dispute With Alfa Wassermann.
PR Newswire; Aug 4, 2009; 700+ Words ...Data and Intellectual Property to Alfa Wassermann NEW YORK, Aug. 4 /PRNewswire...today that the Company and Alfa Wassermann S.p.A. have settled a dispute over...the settlement agreement, Alfa Wassermann is paying Keryx US$3,500...
ALFA WASSERMANN S.p.A.-Company Report.
M2 Presswire; Jan 26, 2009; 531 Words ...26 January 2009-www.companiesandmarkets.com: ALFA WASSERMANN S.p.A.-Company Report(C)1994-2009 M2 COMMUNICATIONS...companiesandmarkets.com adds new report: ALFA WASSERMANN S.p.A.-Company Report Private Company Reports...
Patent No. 7,612,199 Issued on Nov. 3, Assigned to Alfa Wassermann for Polymorphic Form (Italian Inventors)
US Fed News Service, Including US State News; Nov 4, 2009; 458 Words ...form. The inventors were issued U.S. Patent No. 7,612,199 on Nov. 3. The patent has been assigned to Alfa Wassermann S.p.A., Bologna. According to the abstract released by the U.S. Patent & Trademark Office...
Check Us Out GreenArrowStock.com: KERX, SPNG, EVRM stocks on the move.
M2 Presswire; Aug 4, 2009; 700+ Words ...Settles License Dispute With Alfa Wassermannard Keryx Biopharmaceuticals...that the Company and Alfa Wassermann S.p.A. have settled a dispute...settlement agreement, Alfa Wassermann is paying Keryx US$3...mentioned, "Between Dick's [Richard Weitzel] persistent...
Salix Pharmaceuticals' New Drug Application for LUMENAX -Rifaximin- for the Treatment of Travelers' Diarrhea Accepted for Filing by FDA.
Business Wire; Feb 25, 2002; 700+ Words ...gastrointestinal tract. Salix licensed U.S. and Canadian rights to rifaximin from Alfa Wassermann S.p.A. Currently, the product is marketed in Italy by Alfa Wassermann under the trade name Normix(R...
Salix Pharmaceuticals Receives U.S. FDA Approvable Letter for Rifaximin.
Business Wire; Oct 25, 2002; 700+ Words ...Salix licensed rifaximin from Alfa Wassermann S.p.A. The product has been marketed in Italy since 1988 by Alfa Wassermann under the trade name Normix(R...affects 60,000 patients in the U.S. A clinical study of the use of...
News and FDA Updates for Javelin (NYSE:JAV), Thermo Fisher (NYSE:TMO), Keryx (Nasdaq:KERX), LabCorp (NYSE:LH).
M2 Presswire; Aug 5, 2009; 700+ Words ...conference call to discuss the Company's quarterly financial condition...KERX) announced the Company and Alfa Wassermann S.p.A. have settled a dispute over...the settlement agreement, Alfa Wassermann is paying Keryx US$3,500,000...
Salix submits NDA for Rifaximin.
BT Catalyst; Feb 1, 2002; 497 Words ...gastrointestinal tract. Salix licensed U.S. and Canadian rights to rifaximin from Alfa Wassermann S.p.A. of Bologna, Italy. Currently...product is marketed in Italy by Alfa Wassermann under the trade name Normix [R...
SALIX SECURES NORTH AMERICAN RIGHTS TO NORMIX(TM)
PR Newswire; Jun 24, 1996; 700+ Words ...announced today that it has acquired U.S. and Canadian development and distribution...gastrointestinal and respiratory tract diseases from Alfa-Wassermann, S.p.A. of Bologna, Italy. Alfa- Wassermann invented Normix(TM), which is currently...
Salix Pharmaceuticals Submits New Drug Application for Rifaximin for the Treatment of Travelers' Diarrhea.
Business Wire; Dec 27, 2001; 700+ Words ...gastrointestinal tract. Salix licensed U.S. and Canadian rights to rifaximin from Alfa Wassermann S.p.A. Currently, the product is marketed in Italy by Alfa Wassermann under the trade name Normix(R...
Salix Pharmaceuticals Acquires U.S. Right to Lupin's Proprietary Bioadhesive Technology for Extended Release Rifaximin Product.
Business Wire; Oct 5, 2009; 700+ Words ...rights to market rifaximin in North America from Alfa Wassermann S.p.A. in Bologna, Italy. Alfa Wassermann markets rifaximin in Italy under the trade...treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or...
Lupin Licenses US Rights for Proprietary Bioadhesive Technology for Rifaximin to Salix Pharmaceuticals.
PR Newswire; Oct 5, 2009; 700+ Words ...rights to market Rifaximin in North America from Alfa Wassermann S.p.A. in Bologna, Italy. Alfa Wassermann markets Rifaximin in Italy under the trade...Anti-TB and Cephalosporins. The Company's R&D endeavors have resulted in significant...
Focus on the World Ion-Selective Clinical Lab Analyzers Market.
Canadian Corporate News; Jul 7, 2008; 700+ Words ...players worldwide such as Abbott Point of Care, Alfa Wassermann S.p.A., Alfa Wassermann, Inc., Beckman Coulter Inc., F. Hoffmann...Sysmex II-17 Beckman Coulter Takes Over Dako's Cytometry Instrumentation Business II-17 Beckman...
Salix Pharmaceuticals announces new Senior Vice President, Sales & Marketing.
PR Newswire; Jun 14, 2000; 700+ Words ...market these products. Salix's lead product is balsalazide disodium...specific antibiotic, licensed from Alfa Wassermann, S.p.A., an Italian company. Rifaximin...has been marketed in Italy by Alfa Wassermann for several years and is used for...
Salix Pharmaceuticals reports 2000 first quarter financial results.
PR Newswire; May 12, 2000; 700+ Words ...specific antibiotic, licensed from Alfa Wassermann, S.p.A., an Italian company. Rifaximin...has been marketed in Italy by Alfa Wassermann for several years and is used for...share amounts) (Expressed in U.S. Dollars) March 31, December...
Ligand's Targretin Capsules Approved in Europe, Targretin Gel European Application Submitted; Ligand to Receive $3.5 Million Milestone Payments From Elan.
Business Wire; Apr 2, 2001; 700+ Words ...partners, Elan, Ferrer and Alfa Wassermann, to initiate marketing...November 2000. The U.S. Food and Drug Administration...Ferrer Internacional, S.A., for marketing and...and South America; Alfa Wassermann S.p.A. for marketing and...
AFSM International Announces 2005 Education Summit Committee and Membership Committee Leadership.
Business Wire; Mar 7, 2005; 700+ Words ...General Manager, Alfa Wassermann Diagnostic Technologies...Vice President, Alfa Wassermann); Ron Licas (Senior...of the Association's annual World Conference--the S-Business Education...Diebold); Keith P. Evans (Senior Manager...
Salix Pharmaceuticals adopts shareholders rights protection plan.
PR Newswire; Jan 17, 2000; 700+ Words ...specific antibiotic, licensed from Alfa Wassermann, S.p.A., an Italian company. Rifaximin...has been marketed in Italy by Alfa Wassermann for several years and is used for...described in more detail in Salix's reports on Form 10-K, Form 10...
Rifaximin Demonstrates Highly Statistically Significant Results in Prevention of Hepatic Encephalopathy in Pivotal Phase 3 Study.(Report)
Clinical Trials Week; Oct 20, 2008; 700+ Words ...seven years of marketing exclusivity in the U.S. if rifaximin gains approval from the FDA...rights to market rifaximin in North America from Alfa Wassermann S.p.A. in Bologna, Italy. Alfa Wassermann markets rifaximin in Italy under the trade...
Salix Pharmaceuticals, Ltd. Announces Return of Colazide(R) Marketing and Distribution Rights From Astrazeneca.
PR Newswire; Dec 22, 1999; 700+ Words ...specific antibiotic, licensed from Alfa Wassermann, S.p.A., an Italian company. Rifaximin...has been marketed in Italy by Alfa Wassermann for several years and is used for...described in more detail in Salix's reports on Form 10-K, Form 10...
83 results: 1 | 2 | 3 | 4 | 5

Find articles, research, and archives